PlainRecalls
FDA Drug Low Class III Terminated

Mircette (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispensers X 28 tablets, Rx only Teva Pharmaceuticals, USA, Sellersville, PA. NDC 51285-114-58

Reported: July 23, 2014 Initiated: June 17, 2014 #D-1437-2014

Product Description

Mircette (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispensers X 28 tablets, Rx only Teva Pharmaceuticals, USA, Sellersville, PA. NDC 51285-114-58

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
984 blister packs
Distribution
Nationwide
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Mircette (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mg, 6 Cyclic dispensers X 28 tablets, Rx only Teva Pharmaceuticals, USA, Sellersville, PA. NDC 51285-114-58. Recalled by Teva Pharmaceuticals USA. Units affected: 984 blister packs.
Why was this product recalled?
Failed Impurities/Degradation Specifications: out of specification impurity test results.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 23, 2014. Severity: Low. Recall number: D-1437-2014.